Cassava Sciences



Ebitda Cambiamento Data
Abbott USD 2.66B 265M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Cassava Sciences USD -29227000 1.14M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Geron USD -19908000 8.28M 2024-12
J&J USD 6.12B 1.51B 2024-12
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06



Cassava Sciences - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.